NetworkNewsBreaks – VIVO Cannabis Inc. (TSX: VIV
Post# of 111
VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that the company, its production facilities and medical clinics are all continuing to react to COVID-19 with adjustments to internal business practices consistent with the guidelines of public health authorities. Among other highlights from the update, the company reported that it is encouraging all to suspend travel, work from home when possible, and increase the use of personal protective equipment to lessen the risk of COVID-19 exposure and spread. VIVO Cannabis has also implemented more rigorous cleaning and sanitization practices across all of its sites. At the time of the news release, the company’s production facilities are continuing operations and have no confirmed cases of COVID-19. In addition, has temporarily suspended all in-clinic visits at its Harvest Medicine centers in Calgary, Edmonton, Moncton and Dartmouth and has expanded its telemedicine platform of phone and video consultations, including its HMED Connect App. VIVO Cannabis’ devoted team of clinicians and educators continue to be available and provide support. “As we navigate this ever-evolving situation, we have implemented several measures to protect our employees, while allowing us to continue to operate our business,” VIVO Cannabis CEO Barry Fishman stated in the news release. “We are continuing to monitor the latest developments and the guidance from government bodies and public health authorities. Our commitment to strong corporate governance, sound business judgement and proactive actions are more important now than ever.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer